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Abstract 
 
Objectives 
The dual epidemics of tuberculosis (TB) and HIV have devastated communities in Southern 
Africa.  There is increasing imperative for coordination between TB and HIV services but 
how best to accomplish this remains unclear.  We describe the development and operation 
of integrated TB and HIV care at the Martin Preuss Centre in Lilongwe, Malawi. 
 
Methods 
We used a case study approach to describe the integrated TB/HIV service and to illustrate 
successes and challenges faced by service providers. We quantified effective TB and HIV 
integration using indicators defined by the World Health Organization. 
 
Results 
The Martin Preuss Centre is a multi-partner organization bringing together governmental and 
non-governmental providers of HIV and TB services. The custom-designed building 
facilitates patient flow and infection control, and other important elements include 
coordinated leadership; joint staff training and meetings; and data systems prompting 
coordinated care. Some integrated services have worked well from the outset, such as 
promoting HIV testing among TB patients (96% of TB patients had documented HIV status 
in 2009). Other aspects of integrated care have been more challenging, for example 
achieving high uptake of antiretroviral therapy among HIV-positive TB patients, and 
combining data from paper and electronic systems. Good TB treatment outcomes (>85% 
cure or completion) have been achieved amongst both HIV-positive and HIV-negative 
individuals. 
 
Conclusions 
High-quality integrated services for TB and HIV care can be provided in a resource-limited 
setting. Lessons learned may be valuable for service providers in other settings of high HIV 
and TB prevalence. 
 3 
Introduction 
 
Infection with human immunodeficiency virus (HIV) dramatically increases the risk of active 
tuberculosis (TB) (Dye & Williams 2010) and TB is the leading cause of death in HIV-
infected individuals (WHO 2009).  WHO guidelines recommend that antiretroviral therapy 
(ART) is started as soon as possible for all patients with HIV-associated TB (WHO 2010), 
underlining the imperative for effective coordination of TB and HIV services, but how best to 
accomplish this remains unclear (Legido-Quigley et al. 2010), (Theobald et al. 2009). 
 
Malawi has a generalized HIV epidemic; 68% of TB cases have HIV infection (USAID 
2009).  Although the National TB control programme (NTP), and the National AIDS 
Commission collaborate closely at national policy level, the two programmes remain 
separate with their own directorates and funding streams. 
We describe the development, delivery and outcomes of integrated TB/HIV care at a 
purpose-built clinic in Malawi, and report lessons learned. 
Methods 
We used a case study approach, and the WHO framework of "building blocks" of a health 
system (WHO 2007), to describe integrated TB/HIV services in a clinic in Malawi and 
highlight the challenges faced by service providers in resource-limited settings.  We 
quantified effective TB/HIV integration using WHO-defined indicators (WHO 2009).  Short-
term indicators of collaborative activities, defined as “outcomes”, include the proportion of TB 
patients tested for HIV; longer-term, patient-relevant indicators are defined as “impacts” (e.g. 
the proportion of death as a TB treatment outcome).  
 
 
Model of TB/HIV integrated care 
Evolution of the Martin Preuss Centre 
 
The evolution of integrated TB/HIV care at this centre is summarized in Table 1. In 2001 the 
Lighthouse Trust, a non-governmental organization, opened the first specialist HIV centre in 
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Malawi (Phiri et al. 2004).  In December 2006, the Lighthouse, in partnership with Lilongwe 
District Health Office, opened the purpose-built Martin Preuss Centre (MPC), providing 
integrated TB/HIV care, co-located with largest TB registration centre in Malawi.  
Service delivery 
Package of integrated services and management 
 
MPC operates as a partnership between the Lighthouse, the District Health Office, the NTP 
and the HIV/AIDS department at the Ministry of Health.  
The clinic comprises three units: the ART unit, the HIV testing unit and the TB unit, which 
has a sputum submission ("chronic cough") subunit.  MPC operates without doctors; clinical 
officers (who train for three years to obtain a diploma in clinical medicine), nurses, health 
surveillance assistants (who have ten weeks training in public health) and administrative 
staff provide all services. 
Infrastructure and clinic flow 
Building 
The clinic was purpose-built to facilitate infection control; measures include open-air waiting 
areas.  The ART and HIV testing units are located around a central courtyard (Figure 1) 
whereas the sputum submission unit and TB unit are accessed using an exterior walkway, 
separating TB suspects and patients from HIV clinic attendees. 
 
Clinic flow 
From the front desk, patients are directed by colour-coded signs to the appropriate waiting-
area for educational sessions (see Figure 1).  
 
TB suspects (chronic coughers): a health surveillance assistant enquires about 
symptoms, past medical history and reviews the patient-held "health passport" for 
documentation of HIV status.  Patients with unconfirmed HIV status attend the HIV testing 
room within the TB unit for rapid testing and in-session results.  Patients are instructed on 
how to submit sputum samples; they return for results after three days with a treatment 
"guardian", in case TB treatment needs to be commenced. Patients with negative sputum 
smears undergo chest radiography, and return the next day with the radiograph for review 
by a TB clinical officer. 
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TB patients: confirmed TB patients are registered and issued with a paper TB master-card 
[see Appendix 1] and TB identity card.  The HIV testing team, in an adjacent room, provides 
rapid HIV testing to every TB patient before TB medication is dispensed.  A TB clinical 
officer trained in ART provision reviews all HIV-positive TB patients; prescribes co-
trimoxazole and TB treatment (dispensed from TB pharmacy) the same day; and instructs 
the patients to make an appointment for an ART education session within the week.  
Patients return with a guardian within 2-3 weeks to see a TB clinical officer to start ART.  
ART follow-up care is provided at the TB unit for the duration of the TB treatment.  After TB 
treatment completion, patients on ART are transferred to the ART unit to continue on life-
long ART. 
 
HIV testing clients:  following group then individual pre-test counseling, HIV rapid testing 
is performed anonymously, with data on sex, age and marital status only collected in a 
paper register. If a second test confirms reactive status, the patient is referred to the ART 
unit for registration, same-day clinical staging by an ART clinical officer, and blood sample 
for CD4 count (turnaround time 1-2 weeks).  
 
ART and pre-ART patients:  ART-eligible patients must bring a treatment "guardian" and 
attend an education session about ART and adherence before starting ART. Uncomplicated 
patients on ART are seen by a nurse at follow-up; ART clinical officers see all "complicated" 
patients, including children, patients with severe side effects and those on second-line ART 
and review ART and CPT eligibility among pre-ART patients. 
 
The electronic data system includes prompts to ensure that ART and pre-ART patients are 
screened for TB at each visit; TB suspects (defined by national guidelines as those with 
cough [of any duration], fever, night sweats or weight loss) are referred to the "chronic 
cough" unit.  The ART clinical officer provides TB and ART care within the ART unit if the 
patient is diagnosed with TB, thus maintaining continuity of care.  
 
Human resources 
TB unit staff are government employees whereas the ART and HIV testing unit staff are 
Lighthouse employees with public and private funding.  The lead clinical officer/operational 
manager is employed by District Health Office with performance-based support from the 
Lighthouse. Training for all staff follows national recommendations, and there is ad hoc 
cross-cover by appropriately trained staff. 
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Staff from all units attend daily brief organizational meetings, which provide a platform for 
discussion of clinical, logistical or managerial issues. 
 
Information management 
Data systems 
Demographic data are entered into an electronic system and a bar code is placed in the  
health passport, held by most Malawians.   
 
ART patient data, including blood results and medication, are captured directly into an 
electronic system.  Each patient also has a paper ART master-card [Appendix 2], used if 
the patient transfers to another clinic.  The pharmacy and „chronic cough‟ unit are linked to 
the electronic data system; a printed sticker is placed on the paper ART master-card 
whenever medication is issued.  A separate paper-based “chronic cough” register 
[Appendix 3] captures data on history, HIV status and sputum results.  TB-related data are 
entered in a paper register and master-card, but the TB clinical officer can access ART data 
on the electronic data system.   
 
Monitoring and evaluation of collaborative TB/HIV activities 
For patients who complete TB treatment at their local DOTS centre, TB master-cards are 
sent back to MPC on TB treatment completion or default, and treatment outcomes are 
updated in the central TB register. TB data from the paper register are retrospectively 
entered by Lighthouse staff into an offline electronic database and matched with ART data 
using patient identifiers such as name, date of birth and address.  This process is time-
intensive and error-prone, but essential for evaluation of outcomes of HIV-positive TB 
patients.  Monitoring and evaluation of ART and pre-ART care is simplified by virtue of the 
real-time electronic data system. 
 
Measures of effectiveness of integration of TB/HIV care 
Table 2 shows indicators of integration of TB/HIV care (WHO 2009) from 2007-2009.  A high 
percentage of TB patients have HIV status recorded in the TB register (93% in 2007 and 
2008, and 96% in 2009).  The percentage of HIV-positive TB patients started or continued 
on ART during TB treatment has improved from 53% (501/946) in 2007 to 68% (775/1138) 
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in 2009.  TB outcomes by HIV status are shown in Table 3; of note is the high proportion of 
patients achieving cure or treatment completion, and the low TB case fatality rates in HIV-
positive TB patients (4% in 2007, 2008 and 2009).   
 
Discussion 
Some integrated TB/HIV services at MPC have been successful from the outset, such as the 
high uptake of HIV testing of TB patients, whilst other interventions have required refinement 
to overcome barriers, summarised in Table 4.   
Lessons learnt 
 
Partnership between different agencies 
MPC is a marriage between two agencies with distinct organizational cultures; Lighthouse 
staff are highly motivated, whereas staff motivation can be a challenge in the public health 
sector. Disparities in style of team management and pay may accentuate this. Efforts to 
address this issue include appointment of an MPC Team Leader who provides a 
communication bridge between units, improving co-ordination. Regular joint training and 
feedback fosters a culture of continual service improvement, and the benefits to patients 
(such as ART for TB/HIV patients) are visible and motivating to staff. 
 
ART initiation in TB patients 
Although the proportion of HIV-positive TB patients initiating ART has increased since 
integration of TB/HIV care, it remains suboptimal.  According to clinic protocol, HIV-positive 
TB patients are reviewed by a TB clinical officer; however, in practice, health surveillance 
assistants, who are not trained in ART provision, often see smear-positive HIV-positive TB 
patients, start TB treatment and refer onto the local DOTS centre, and occasionally omit to 
arrange follow-up for ART initiation.   
 
Some HIV-positive TB patients decide to start ART at a clinic closer to home, but some 
peripheral ART clinics are reluctant to manage patients on concurrent TB treatment due to 
concerns including drug interactions and immune reconstitution syndrome.  Lighthouse/MPC 
ART clinical officers currently provide specialist input at peripheral ART clinics to address 
this.   
 
TB patients diagnosed with HIV in the TB unit receive ART from the ART pharmacy, 
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representing an infection control risk: ideally, ART should be dispensed by TB clinicians in 
their clinic rooms, and staff training is needed to overcome this barrier. 
 
Data management and monitoring and evaluation 
A key component of successful integration is the availability of integrated monitoring and 
evaluation tools.  The revision of TB monitoring tools to capture HIV data was an important 
step in the evolutionary process. The current process to link the two systems is arduous and 
error-prone and raises concerns about data quality. Further technological advances are in 
progress in order to standardize data management across the centre and there are plans to 
pilot an electronic data system for coordinated ART and TB management. 
 
Limitations of the case study approach include lack of a comparator, hence we cannot define 
unequivocally what service components are critical to success.    MPC is relatively well-
resourced, but not all the elements which we believe contribute to good outcomes are 
resource-related, e.g. leadership and facilitating communications.  The purpose-built clinic 
facilitates infection control and this cannot immediately be replicated elsewhere, but some 
components could be introduced at low cost, such as open-air waiting areas.   
 
In conclusion, integration of care for TB and HIV has been greatly facilitated by the 
establishment of this purpose-built centre. The physical design of the building facilitates 
patient flow and infection control; however, successful integration of care depends on much 
more than architecture. Bringing staff from the two programmes together with daily meetings 
and joint training, and strong leadership, with a culture of seeking continual improvements to 
care, seem equally important in the success of this facility.   
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Table 1. Evolution of integrated tuberculosis and HIV services at the Martin Preuss 
Centre 
 
Timeline Details 
2001 Founding of the Lighthouse Trust, a non-governmental organization, as the first 
specialist HIV centre at Kamuzu Central Hospital, Malawi 
2002 Malawi National Tuberculosis Programme and National AIDS Commission develop 3 
year plan for HIV/TB activities including provision of antiretroviral therapy (ART) and 
cotrimoxazole for all HIV-positive TB cases 
2004 National ART scale-up plan implemented, based on principles of DOTS strategy and 
experience from Malawi's highly effective TB control programme 
December 2006 Martin Preuss Centre opened at Bwaila Hospital as a partnership between Lighthouse 
trust and Lilongwe District Health Office.  
All HIV-positive TB patients initiated on antiretroviral therapy regardless of CD4 count 
 Routine provider-initiated screening for TB signs and symptoms of all HIV-positive 
patients at every antiretroviral therapy visit 
 6-month rifampicin-based TB regimen: fixed dose combination as daily directly 
observed therapy for newly-diagnosed TB patients 
 Co-trimoxazole preventive therapy provision immediately following HIV diagnosis in 
HIV-positive TB patients 
 Opt-out provider-initiated HIV counseling and testing for TB patients 
April 2007 Piloting of revised national TB monitoring tools (master-cards and paper register) 
incorporating data on HIV diagnosis, antiretroviral therapy and co-trimoxazole 
preventive therapy.  
January 2009 TB clinical officers trained to initiate and provide antiretroviral therapy integrated with 
TB treatment to all HIV-positive TB patients for the duration of TB treatment.  
Feb 2009 Early antiretroviral therapy initiation (2 weeks after TB treatment initiation) for HIV-
positive TB patients. 
April 2009 Provider initiated opt-out HIV testing and counseling for TB suspects – “chronic 
coughers” 
September 2010 Register for chronic coughers modified to include HIV testing and counseling results 
October 2010 Development of electronic monitoring tools for coordinated HIV and TB management 
 
 12 
Table 2.  Measures of effectiveness of TB and HIV care integration at the Martin Preuss Centre 
 
Calendar 
period of 
reporting* 
Measure of effectiveness of integration 
“Outcome” measure “Impact” measure 
% TB pts with HIV 
status recorded in 
register 
 
 
n/total (%) 
% TB suspects 
with HIV result 
recorded in 
„register** 
 
n/total (%) 
% HIV+ pts on 
ART recorded as 
having TB screen 
at last visit 
 
n/total (%) 
% HIV+ TB pts started/ continued on during TB 
treatment: 
% HIV+ pts alive and retained in care after starting ART 
at: 
ART 
 
 
n/total (% ) 
ART during first 
2mths of TB 
treatment 
n/total (%) 
CPT 
 
 
n/total (% ) 
6 months 
 
 
n/total (%) 
1 year 
 
 
n/total (%) 
2 years 
 
 
n/total (%) 
2007 3464/3720 (93) - - 501/946 (53) - - 1615/2010 (80) 1421/2010 (71) 1226/2010 (61) 
2008 3983/4282 (93) - - 758/1289 (59) 221/1289 (17) 836/955 (88) 2142/2716 (79) 1951/2716 (72) - 
2009 3092/3231 (96) 2476/3983 (62) 2649/2851 (93) 775/1138 (68) 434/1138 (38) 1076/1138 (95) 2233/2851 (78) - - 
* Each calendar period starts from the 1
st
 January to 31
st
 December. 
**
 
Reporting period starts from 1
st
 April 2009 
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Table 3. TB treatment outcomes by HIV status 
 
* A significant proportion of TB treatment outcomes for 2009 are outstanding as master-cards have not yet to been returned by the peripheral health clinics 
 
 
Calendar 
period of 
reporting 
 
TB treatment outcomes by HIV status 
HIV-positive cases 
n/total (%) 
 
HIV-negative cases 
n/total (%) 
Cure/ 
complete 
Died Failure Default Transfer Not known 
 
Cured/ 
complete 
Died Failure Default Transfer Not known 
2007 
 
2013/2326 
(87) 
104/2326 
(4) 
5/2326 
(0) 
80/2326 
(3) 
81/2326 
(3) 
43/2326 
(2) 
 
947/1093 
(86) 
35/1093 
(3) 
4/1093 
(0) 
50/1093 
(5) 
38/1093 
(3) 
19/1093 
(2) 
2008 
 
2220/2544 
(87)  
93/2544 
(4) 
5/2544 
(0) 
68/2544 
(3) 
44/2544 
(2) 
114/2544 
(4) 
 
1131/1305 
(87) 
36/1305 
(3) 
12/1305 
(1) 
34/1305 
(3) 
31/1305 
(2) 
61/1305 
(5)  
2009 
 
1337/2005 
(67) 
88/2005 
(4) 
5/2005 
(0) 
38/2005 
(2) 
45/2005 
(2) 
492/2005 
(25)* 
 
733/1011 
(73) 
25/1011 
(2) 
3/1011 
(0) 
22/1011 
(2) 
22/1011 
(2) 
206/1011 
(20)* 
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 Table 4.  Principal issues concerning integration of care for TB and HIV 
WHO recommended 
collaborative TB/HIV 
activities
15
 
Issues Approach Assessment 
Establish the 
mechanisms for 
collaboration 
Effective coordination 
of two separate 
programmes  
Management 
Team leader jointly appointed by District Health Office 
with performance based support from the Lighthouse, 
chairs daily clinical meetings attended by team members 
from each unit; these serve as a platform to discuss any 
clinical, logistical or managerial issues 
Training for service providers 
Standardized training in HIV testing, ART provision, TB 
monitoring tools and TB treatment for all clinical officers 
and nurses in both programmes 
Higher levels of motivation 
amongst Lighthouse staff 
 
Monitoring and 
evaluation (M&E) of 
collaborative TB/HIV 
activities  
 
National TB monitoring tools (paper register and master-
card) revised to include information on HIV diagnosis, 
ART and CPT; adopted by NTP and scaled up nationally. 
Electronic data system in ART unit and TB unit to capture 
real time ART-related data has made process much 
simpler to perform  
Evaluation of outcomes of HIV+ TB pts requires error-
prone process of retrospectively entering paper-based TB 
data into an offline electronic database 
 
 
Electronic systems facilitate 
M&E of ART and pre-ART 
care  
Laborious, and concerns 
about data quality when 
evaluating outcomes of 
HIV+ TB patients 
Decrease the burden 
of TB in people living 
with HIV/AIDS 
Effective infection 
control to reduce risk 
of nosocomial TB 
transmission 
Architectural design of the building separates TB 
suspects/patients from the other patients 
Open air waiting areas with educational sessions 
promoting cough etiquette and cough hygiene 
Safe sputum collection as patients expectorate sputum at 
home and submit samples to the „sputum submission unit‟ 
attached to the outside of the building  
Not formally assessed 
Maximizing TB case-
finding in ART and 
pre-ART patients 
Inbuilt prompts in the electronic data system during the 
consultation ensure that ART clinical officers and nurses 
perform a symptom screen at each visit for pre-ART and 
ART patients 
High uptake of TB screening 
at each visit achieved 
following implementation of 
electronic data system 
 Introduction of IPT Not implemented as not part of national policy - 
Decrease the burden 
of HIV in TB patients 
Maximizing HIV 
testing for TB patients 
Patient flow within the TB unit incorporating HIV testing as 
an integral component of care prior to dispensing TB 
medication 
High coverage of HIV 
testing among TB patients 
from the outset 
Maximizing CPT 
provision for HIV+ TB 
patients 
 
Training and regular clinical meetings ensure that TB 
clinical officers routinely prescribe CPT for all HIV+ TB pts 
Access to CPT enhanced by ease of availability of CPT 
from the TB pharmacy 
High uptake achieved from 
outset.   
 
Increasing the 
proportion of HIV+ TB 
patients started on 
ART  
Increased number TB clinical officers required to provide 
„medicalised‟ ART care to HIV+ TB pts within the TB unit.  
Addressing patient negative perceptions about ART and 
TB co-treatment by the production of leaflet stating the 
benefits of treating both diseases 
Improvement seen over time 
but target of 75% HIV+ TB 
pts on ART during TB 
treatment yet to be achieved 
 Maximizing HIV 
testing for „TB 
suspects‟ 
TB suspects routinely recommended to go for HIV testing 
within TB unit  
Aim to provide more patient education sessions in the 
waiting area to increase awareness in service users about 
importance of HIV testing 
Uptake of HIV testing in TB 
suspects below target, 
probably because HIV 
testing not embedded within 
the care pathway.   
ART= anti-retroviral therapy; CPT= co-trimoxazole preventative therapy; M&E= monitoring and evaluation; NTP= National TB 
control programme; IPT= isoniazid preventive therapy 
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Figure 1.  Building plan of the Martin Preuss Centre 
 
